SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-16-011337
Filing Date
2016-07-29
Accepted
2016-07-29 06:35:14
Documents
2
Period of Report
2016-07-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_072916.htm 8-K 11078
2 PRESS RELEASE exh_991.htm EX-99.1 3667
  Complete submission text file 0001171843-16-011337.txt   15983
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 161791916
SIC: 2834 Pharmaceutical Preparations